Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients

ID: ITN022ST

Description: Alemtuzumab (Campath-1H) is a man-made antibody used to treat certain blood disorders. This study will evaluate treatment of kidney transplant recipie...

Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis

ID: ITN020AI

Description: This is a phase II, double blind, placebo-controlled, multicenter, randomized study of the efficacy and safety of atorvastatin (80 mg/day) in particip...

Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients

ID: ITN029ST

Description: This is a prospective multicenter, open-label, single-arm trial in which 20 pediatric recipients of parental living-donor liver allografts will underg...